BICUK: BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill Patients

Sponsor
University of Ulm (Other)
Overall Status
Completed
CT.gov ID
NCT00736827
Collaborator
University of Wuerzburg (Other)
51
1
52
1

Study Details

Study Description

Brief Summary

The purpose of this study is to find out whether acute renal failure is associated with BK virus reactivation in postoperative/posttraumatic critically ill patients with severe SIRS/sepsis and shock.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Polyomavirus BK virus (BKV) infection and nephropathy is a significant cause of allograft dysfunction in kidney transplantation. Clinical manifestation ranges from BK viremia and nephritis to renal dysfunction. It has been suggested that BK virus reactivation alone is not sufficient to cause BK viremia and nephropathy, thus a second hit is essential for kidney specific damage, such as an inflammatory reaction or ischemia. Critically ill postoperative/posttraumatic patients via the systemic inflammatory response syndrome (SIRS) and the compensatory antiinflammatory response syndrome (CARS) are at increased risk to develop organ dysfunctions, such as acute renal failure. CARS, reflecting postoperative/posttraumatic immunosuppression, may favor viral reactivation. However, prevalence of BK viremia in critically ill postoperative/posttraumatic patients has up to now not been systematically evaluated. Moreover, it is not known whether BK viremia is associated with a distinct biomarker pattern in these patients. Therefore, the present study is performed to clarify whether postoperative/posttraumatic immunosuppression is associated with BK viremia, and acute renal failure with BK virus reactivation, respectively.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    51 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill Patients
    Study Start Date :
    Aug 1, 2008
    Actual Primary Completion Date :
    Aug 1, 2012
    Actual Study Completion Date :
    Dec 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Patients with non-septic shock

    Postoperative/posttraumatic surgical critically ill patients with non-septic shock with threatening acute renal failure

    Patients with septic shock

    Postoperative/posttraumatic surgical critically ill patients with septic shock with threatening acute renal failure

    Outcome Measures

    Primary Outcome Measures

    1. Association between BK virus reactivation and acute renal dysfunction [Daily monitoring of acute renal failure, first day of acute renal dysfunction, first days on hemodiafiltration, first day after hemodiafiltration, before demission from intensive care unit or death.]

    Secondary Outcome Measures

    1. Pattern of biomarkers and surface markers on leukocytes. [First day of acute renal dysfunction, first days on hemodiafiltration, first day after hemodiafiltration, before demission from intensive care unit or death.]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Critically ill, postoperative/posttraumatic patients with threatening acute renal failure
    Exclusion Criteria:
    • Life expectancy < 24 hours

    • Participation in other trials

    • Known or suspected pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Clinic of Anesthesiology Ulm Germany 89070

    Sponsors and Collaborators

    • University of Ulm
    • University of Wuerzburg

    Investigators

    • Principal Investigator: Manfred Weiss, MD, MBA, University Hospital Ulm

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Manfred Weiss, Professor, MD, MBA, University of Ulm
    ClinicalTrials.gov Identifier:
    NCT00736827
    Other Study ID Numbers:
    • Anae_ICU_Ulm_BKV
    First Posted:
    Aug 18, 2008
    Last Update Posted:
    Dec 4, 2015
    Last Verified:
    Dec 1, 2015

    Study Results

    No Results Posted as of Dec 4, 2015